Review
Accepted on 24 Apr 2025
Friend or foe: the role of platelets in acute lung injury
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1556923
- Frontiers in Immunology
- Inflammation
- Articles
Type at least 3 characters
5,066 articles
Review
Accepted on 23 Apr 2025
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561946
Original Research
Accepted on 23 Apr 2025
Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Inflammation-Induced Depression by Modulating Peripheral-Central Inflammatory Cytokines and the NF-κB Pathway in rats
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1536056
Original Research
Accepted on 23 Apr 2025
Intrauterine infusion of autologous platelet-rich plasma modulates endometrial immune status and improves pregnancy outcomes in patients with persistent chronic endometritis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1528522
- 165 views
Original Research
Accepted on 22 Apr 2025
Changes in immune cell signatures during early infection reflect decoupling of capillary perfusion and glycocalyx dimensions
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1589959
Original Research
Accepted on 22 Apr 2025
Thymic Stromal Lymphopoietin-activated Basophil Promotes Lung Inflammation in Mouse Atopic March Model
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1573130
Review
Accepted on 22 Apr 2025
The NLRP3 Inflammasome: A Therapeutic Target of Phytochemicals in Treating Atherosclerosis (a systematic review)
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568722
Original Research
Accepted on 22 Apr 2025
Chitinase-1 inhibition attenuates metabolic dysregulation and restores homeostasis in MASH animal models
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544973
Review
Accepted on 22 Apr 2025
Specialized pro-resolving mediators in neutrophil apoptosis regulation: unlocking novel therapeutic potential in kidney diseases
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1589923
Original Research
Accepted on 22 Apr 2025
Human Fcγ-receptors selectively respond to C-reactive protein (CRP) isoforms
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1598605
Original Research
Accepted on 22 Apr 2025
mTOR drives tertiary lymphoid tissue formation and growth in the kidney
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1527817
Review
Accepted on 22 Apr 2025
SARM1: a key multifaceted component in immunoregulation, inflammation and neurodegeneration
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1521364
Brief Research Report
Accepted on 22 Apr 2025
C-Reactive Protein conformations and their association with the IL-1β/IL-6 pathway in ocular inflammatory conditions
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1601145
Original Research
Published on 22 Apr 2025
Associations between type III interferons, obesity and clinical severity of COVID-19
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1516756
- 345 views
Original Research
Accepted on 21 Apr 2025
Heat shock protein 90α may serve as a biomarker for mild cognitive impairment in type 2 diabetes mellitus patients without diabetic nephropathy
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1516975
Clinical Trial
Accepted on 21 Apr 2025
A Phase 2a Double-Blind, Placebo-Controlled, Randomized Clinical Trial Evaluating the Efficacy and Safety of NuGel, a Novel Topical GPCR19-Mediated Inflammasome Inhibitor, in Patients with Mild to Moderate Atopic Dermatitis: A Proof-of-Concept Study with Post-Hoc Biomarker Analysis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560447
- 156 views